Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptor by Leibman, Rachel S, Richardson, Max W, Ellebrecht, Christoph T, Maldini, Colby R, Glover, Joshua A, Secreto, Anthony J, Kulikovskaya, Irina, Lacey, Simon F, Akkina, Sarah R, Yi, Yanjie, Shaheen, Farida, Wang, Jianbin, Dufendach, Keith A, Holmes, Michael C, Collman, Ronald G, Payne, Aimee S, Riley, James L

Get full text

Engineering T Cells to Functionally Cure HIV-1 Infection by Leibman, Rachel S, Riley, James L

Get full text

HIV-Resistant and HIV-Specific CAR-Modified CD4+ T Cells Mitigate HIV Disease Progression and Confer CD4+ T Cell Help In Vivo by Maldini, Colby R., Gayout, Kevin, Leibman, Rachel S., Dopkin, Derrick L., Mills, Joshua P., Shan, Xiaochuan, Glover, Joshua A., Riley, James L.

Get full text

Antimicrobial peptides trigger a division block in Escherichia coli through stimulation of a signalling system by Yadavalli, Srujana S., Carey, Jeffrey N., Leibman, Rachel S., Chen, Annie I., Stern, Andrew M., Roggiani, Manuela, Lippa, Andrew M., Goulian, Mark

Get full text

Enterococcus faecalis produces abundant extracellular structures containing DNA in the absence of cell lysis during early biofilm formation by Barnes, Aaron M T, Ballering, Katie S, Leibman, Rachel S, Wells, Carol L, Dunny, Gary M

Get full text

First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti-PD-1 antibody budi... by Shimizu, Toshio, Powderly, John, Abdul Razak, Albiruni, LoRusso, Patricia, Miller, Kathy D, Kao, Steven, Kongpachith, Sarah, Tribouley, Catherine, Graham, Michelle, Stoll, Brian, Patel, Maulik, Sahtout, Mohammad, Blaney, Martha, Leibman, Rachel, Golan, Talia, Tolcher, Anthony

Get full text

Abstract CT207: Phase 1 first-in-human study of ABBV-151 as monotherapy or in combination with budigalimab in patients with locally advanced or metastatic solid tumors by Powderly, John, Shimizu, Toshio, LoRusso, Patricia, Razak, Albiruni, Miller, Kathy, Balar, Arjun, Bruix, Jordi, Michel, Loren, Blaney, Martha, Guan, Xiaowen, Lacy, Susan, Lally, Satwant, Lambert, Stacie, Leibman, Rachel, Vosganian, Gregory, Golan, Talia, Tolcher, Anthony

Get full text

770 Safety, efficacy, and pharmacokinetic results from a phase I first-in-human study of ABBV-151 with or without anti-PD1 mAb (budigalimab) in patients with locally advanced or me... by Tolcher, Anthony, Roda-Perez, Desamparados, He, Kai, Moreno, Victor, Gomez-Roca, Carlos, Jean-Pascal Machiels, Razak, Albiruni, Sahtout, Mohammad, Guan, Xiaowen, Jaryno-Daly, Stacy, Leibman, Rachel, Blaney, Martha, James O’Brien, Lorusso, Patricia, Powderly, John, Golan, Talia, Miller, Kathy, Bruix, Jordi

Get full text

Good Medicine (Usually) by Leibman, Rachel

Get full text

Pilot trial comparing COVID-19 publication database to conventional online search methods by Torfs-Leibman, Camille, Ashikaga, Takamaru, Krag, David, Lunna, Shania, Robtoy, Sarah, Bombardier, Rachel

Get full text

JEWISH OBJECTS AND JEWISH AFFECTS: A Conversation by EICHLER-LEVINE, JODI, GROSS, RACHEL B., LEIBMAN, LAURA A., LEVITT, LAURA S.

Get full text

A gain of function mutation in SlNRC4a enhances basal immunity resulting in broad-spectrum disease resistance by Pizarro, Lorena, Leibman-Markus, Meirav, Gupta, Rupali, Kovetz, Neta, Shtein, Ilana, Bar, Einat, Davidovich-Rikanati, Rachel, Zarivach, Raz, Lewinsohn, Efraim, Avni, Adi, Bar, Maya

Get full text